Price T Rowe Associates Inc Tenaya Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,513,724 shares of TNYA stock, worth $7.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,513,724
Previous 3,346,522
5.0%
Holding current value
$7.84 Million
Previous $17.5 Million
37.76%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TNYA
# of Institutions
99Shares Held
56MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$21 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$17 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$15 Million1.8% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$9.09 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$7.06 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $92.2M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...